Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have earned an average rating of “Moderate Buy” from the five research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has earned an average rating of “Moderate Buy” from the eleven brokerages that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, six have assigned a buy recommendation and one has assigned […]

Viridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and eleven have issued a buy recommendation on the […]

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a buy recommendation and one has issued a strong buy […]

Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been given an average rating of “Buy” by the nine ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, six have given a buy rating and two have given a strong […]

OnKure Therapeutics, Inc. (NASDAQ:OKUR – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have issued a buy recommendation on the company. […]

Shares of Tectonic Therapeutic, Inc. (NASDAQ:TECX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have assigned a buy rating and one has given a […]

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 12 month target price […]

Shares of Monopar Therapeutics Inc. (NASDAQ:MNPR – Get Free Report) have been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, ten have assigned a buy rating and two have given a strong buy rating to […]

Shares of Ovid Therapeutics (NASDAQ:OVID – Get Free Report) have been assigned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and two have given a strong buy recommendation […]